- Title
- FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial
- Creators - without role
- M. Hebbar - Centre Hospitalier Universitaire de LilleB. Chibaudel - Hôpital Saint-AntoineT. André - Institut Sainte CatherineL. Mineur - Institut Sainte CatherineD. Smith - Hôpital Saint-AndréC. Louvet - Institute Mutualiste MontsourisJ. Dutel - Centre Hospitalier de BeauvaisM. Ychou - Institut de Recherche en Cancérologie de MontpellierJ. Legoux - Hôpital Cardiologique du Haut-LévêqueM. Mabro - Hôpital FochR. Faroux - Centre Hospitalier Départemental VendéeD. Auby - Centre Hospitalier LibourneD. Brusquant - GERCORA. Khalil - Cadi Ayyad UniversityS. Truant - Centre Hospitalier Universitaire de LilleA. Hadengue - GERCORC. Dalban - Carcinogénèse épithéliale : facteurs prédictifs et pronostiques - UFC (UR 3181)B. Gayet - Institute Mutualiste MontsourisF. Paye - Hôpital Saint-AntoineF. Pruvot - Centre Hospitalier Universitaire de LilleA. de Gramont - Hôpital Saint-Antoine
- Publication Details
- Annals of Oncology, Vol.26(5), pp.1040-1040
- Identifiers
- 9941077109311
- Academic Unit
- Institut de Recherche en Cancérologie de Montpellier - IRCM
- Language
- English
- Resource Type
- Journal article
- Local Fields
- hal-02284989
Journal article
FOLFOX4 versus sequential dose-dense FOLFOX7 followed by FOLFIRI in patients with resectable metastatic colorectal cancer (MIROX): a pragmatic approach to chemotherapy timing with perioperative or postoperative chemotherapy from an open-label, randomized phase III trial
Annals of Oncology, Vol.26(5), pp.1040-1040
01/05/2015
PMID: 25900678
Metrics
1 Record Views